These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7640484

  • 1. Effect of anti-ICAM-1 and anti-LFA-1 antibodies on rat liver transplantation.
    Degawa H, Watanabe K, Beck Y, Tomikawa S, Nagao T, Uchida H.
    Surg Today; 1995; 25(5):474-6. PubMed ID: 7640484
    [Abstract] [Full Text] [Related]

  • 2. [Involvement of ICAM-1/LFA-1 adhesion molecule set in rat orthotopic liver transplantation].
    Omura T.
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1220-31. PubMed ID: 7868060
    [Abstract] [Full Text] [Related]

  • 3. Blocking of ICAM-1 and LFA-1 in rat liver transplantation.
    Degawa H, Watanabe K, Uchida H, Nagao T, Tomikawa S, Beck Y, Nomura Y, Ichikawa N, Ando Y, Kikuchi K, Ito S.
    Transplant Proc; 1996 Jun; 28(3):1362-3. PubMed ID: 8658695
    [No Abstract] [Full Text] [Related]

  • 4. [Selective immunosuppression with monoclonal antibodies against ICAM-1 and LFA-1 with FK 506 after experimental small intestine transplantation in the rat].
    Gasser M, Otto C, Timmermann W, Gassel HJ, Ulrichs K, Thiede A.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Jun; 115(Suppl I):595-9. PubMed ID: 14518324
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunosuppression by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies of free and vascularized skin allograft rejection.
    Iwata T, Kamei Y, Esaki S, Takada T, Torii S, Yamashita A, Tomida S, Tamatani T, Miyasaka M, Yoshikai Y.
    Immunobiology; 1996 Jul; 195(2):160-71. PubMed ID: 8877393
    [Abstract] [Full Text] [Related]

  • 7. Anti-LFA-1 alpha reduces the dose of cyclosporin A needed to produce immunosuppression in heterotopic cardiac transplanted rats.
    Harrison PC, Madwed JB.
    J Heart Lung Transplant; 1999 Apr; 18(4):279-84. PubMed ID: 10226890
    [Abstract] [Full Text] [Related]

  • 8. Combination of anti-ICAM-1 and anti-LFA-1 monoclonal antibody therapy prolongs allograft survival in rat hind-limb transplants.
    Ozer K, Siemionow M.
    J Reconstr Microsurg; 2001 Oct; 17(7):511-7; discussion 518. PubMed ID: 11598825
    [Abstract] [Full Text] [Related]

  • 9. Effect of anti-intercellular adhesion molecule-1 and anti-leukocyte function associated antigen-1 monoclonal antibodies on rat-to-mouse cardiac xenograft rejection.
    Miwa S, Isobe M, Suzuki J, Makuuchi M, Miyasaka M, Yamazaki S, Kawasaki S.
    Surgery; 1997 Jun; 121(6):681-9. PubMed ID: 9186469
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cardiac allografts in rat recipients with simultaneous use of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies leads to accelerated graft loss.
    Morikawa M, Tamatani T, Miyasaka M, Uede T.
    Immunopharmacology; 1994 Jun; 28(3):171-82. PubMed ID: 7852048
    [Abstract] [Full Text] [Related]

  • 12. Dose dependent immunosuppressive effects of antibodies to ICAM-1 and LFA-1 on hepatic allografts.
    Harihara Y, Sugawara Y, Inoue K, Kubota K, Bandai Y, Makuuchi M, Miyasaka M.
    Transplant Proc; 1996 Jun; 28(3):1794-5. PubMed ID: 8658886
    [No Abstract] [Full Text] [Related]

  • 13. Induction of unresponsiveness to islet xenograft by MMC treatment of graft and blockage of LFA-1/ICAM-1 pathway.
    Grochowiecki T, Gotoh M, Dono K, Takeda Y, Sakon M, Yagita H, Okumura K, Miyasaka M, Monden M.
    Transplantation; 2000 Apr 27; 69(8):1567-71. PubMed ID: 10836363
    [Abstract] [Full Text] [Related]

  • 14. Difference in immunosuppressive effects of antibodies to ICAM-1 and LFA-1 between hepatic and cardiac allografts.
    Harihara Y, Sugawara Y, Inoue K, Kubota K, Bandai Y, Makuuchi M, Miyasaka M.
    Transplant Proc; 1996 Jun 27; 28(3):1368-9. PubMed ID: 8658698
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction of donor-specific tolerance to rat nerve allografts with portal venous donor alloantigen and anti-ICAM-1/LFA-1 monoclonal antibodies.
    Genden EM, Mackinnon SE, Yu S, Flye MW.
    Surgery; 1998 Aug 27; 124(2):448-56. PubMed ID: 9706170
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
    Harrison PC, Mainolfi E, Madwed JB.
    J Heart Lung Transplant; 1998 Feb 27; 17(2):150-7. PubMed ID: 9513853
    [Abstract] [Full Text] [Related]

  • 18. Limb allografts in rats treated with anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Tsuchida Y, Usui M, Naitoh T, Takahashi T, Murakami M, Uede T.
    J Reconstr Microsurg; 1997 Feb 27; 13(2):107-10. PubMed ID: 9044184
    [Abstract] [Full Text] [Related]

  • 19. The F(ab')2 fragment of an anti-ICAM-1 monoclonal antibody attenuates liver injury after orthotopic liver transplantation.
    Nishimura Y, Takei Y, Kawano S, Goto M, Nagano K, Tsuji S, Nagai H, Ohmae A, Fusamoto H, Kamada T.
    Transplantation; 1996 Jan 15; 61(1):99-104. PubMed ID: 8560583
    [Abstract] [Full Text] [Related]

  • 20. Prolongation of hepatic allograft survival with antibodies to ICAM-1 and LFA-1.
    Harihara Y, Sakamoto H, Sanjo K, Otsubo O, Watanabe G, Idezuki Y.
    Transplant Proc; 1994 Aug 15; 26(4):2258. PubMed ID: 7915063
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.